DK1063998T3 - Lægemiddel til profylakse og/eller behandling af mammarkarcinom indeholdende en steroidal aromataseinhibitor - Google Patents

Lægemiddel til profylakse og/eller behandling af mammarkarcinom indeholdende en steroidal aromataseinhibitor

Info

Publication number
DK1063998T3
DK1063998T3 DK99913218T DK99913218T DK1063998T3 DK 1063998 T3 DK1063998 T3 DK 1063998T3 DK 99913218 T DK99913218 T DK 99913218T DK 99913218 T DK99913218 T DK 99913218T DK 1063998 T3 DK1063998 T3 DK 1063998T3
Authority
DK
Denmark
Prior art keywords
prophylaxis
treatment
drug
aromatase inhibitor
mammary carcinoma
Prior art date
Application number
DK99913218T
Other languages
English (en)
Inventor
Alfred Schmidt
Heinrich Wieland
Original Assignee
S W Patentverwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1063998(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S W Patentverwertungs Gmbh filed Critical S W Patentverwertungs Gmbh
Application granted granted Critical
Publication of DK1063998T3 publication Critical patent/DK1063998T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99913218T 1998-03-18 1999-03-03 Lægemiddel til profylakse og/eller behandling af mammarkarcinom indeholdende en steroidal aromataseinhibitor DK1063998T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98104949A EP0943333A1 (de) 1998-03-18 1998-03-18 Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
PCT/EP1999/001374 WO1999047143A1 (de) 1998-03-18 1999-03-03 Medikament zur prophylaxe und/oder behandlung des mammakarzinoms enthaltend einen steroidalen aromataseinhibitor

Publications (1)

Publication Number Publication Date
DK1063998T3 true DK1063998T3 (da) 2003-05-12

Family

ID=8231611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913218T DK1063998T3 (da) 1998-03-18 1999-03-03 Lægemiddel til profylakse og/eller behandling af mammarkarcinom indeholdende en steroidal aromataseinhibitor

Country Status (19)

Country Link
EP (2) EP0943333A1 (da)
JP (1) JP4920822B2 (da)
KR (1) KR100778803B1 (da)
CN (1) CN1168448C (da)
AT (1) ATE230995T1 (da)
AU (1) AU751040B2 (da)
BR (1) BR9908885A (da)
CA (1) CA2324077C (da)
CZ (1) CZ292643B6 (da)
DE (1) DE59904042D1 (da)
DK (1) DK1063998T3 (da)
ES (1) ES2190201T3 (da)
HU (1) HU226105B1 (da)
ID (1) ID26965A (da)
IL (1) IL138292A (da)
PL (1) PL343100A1 (da)
RU (1) RU2225206C2 (da)
SK (1) SK285349B6 (da)
WO (1) WO1999047143A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042411A1 (de) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Exemestan
DE10054294A1 (de) * 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
JP4524296B2 (ja) * 2007-03-30 2010-08-11 生化学工業株式会社 発毛促進剤
DE102007032468A1 (de) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
KR20140040690A (ko) * 2011-01-31 2014-04-03 루콜라스-엠.디. 리미티드 미용학적 용도
TR201816243T4 (tr) 2011-01-31 2018-11-21 Lucolas M D Ltd Aromataz inhibitörlerinin ve antioksidanların kombinasyonları.
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
EP3666276A1 (en) * 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
JPS6345294A (ja) * 1986-04-07 1988-02-26 Shionogi & Co Ltd アロマタ−ゼ阻害ステロイド誘導体
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
FR2656310B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
AU6391894A (en) * 1993-03-16 1994-10-11 Pfizer Inc. Naphthalene derivatives
JPH07215992A (ja) * 1993-12-07 1995-08-15 Teikoku Hormone Mfg Co Ltd ６−又は７−置換アンドロスタ−１，４−ジエン誘導体
EP0777458B1 (en) * 1994-09-14 2000-12-06 Central Sheffield University Hospitals NHS Trust Control of hair growth
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
ATE200978T1 (de) * 1996-03-29 2001-05-15 S W Patentverwertungs Ges M B KOSMETIKUM BZW. KOSMETIKZUSAMMENSETZUNG ZUR GLÄTTUNG UND STRAFFUNG DER HAUT BEI GESTÖRTEM UNTERHAUT-BINDE-FETTGEWEBE, INSBESONDERE BEI DER ßCELLULITEß
CA2632790A1 (en) * 1996-07-22 1998-01-29 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders

Also Published As

Publication number Publication date
RU2225206C2 (ru) 2004-03-10
EP0943333A1 (de) 1999-09-22
BR9908885A (pt) 2000-11-21
ID26965A (id) 2001-02-22
WO1999047143A1 (de) 1999-09-23
IL138292A0 (en) 2001-10-31
JP4920822B2 (ja) 2012-04-18
SK285349B6 (sk) 2006-11-03
HUP0101005A2 (hu) 2001-08-28
CA2324077C (en) 2008-07-29
CZ292643B6 (cs) 2003-11-12
KR100778803B1 (ko) 2007-11-27
PL343100A1 (en) 2001-07-30
EP1063998B1 (de) 2003-01-15
SK13422000A3 (sk) 2001-05-10
KR20010034603A (ko) 2001-04-25
AU751040B2 (en) 2002-08-08
HU226105B1 (en) 2008-04-28
ATE230995T1 (de) 2003-02-15
CN1168448C (zh) 2004-09-29
DE59904042D1 (de) 2003-02-20
EP1063998A1 (de) 2001-01-03
CN1301165A (zh) 2001-06-27
CA2324077A1 (en) 1999-09-23
ES2190201T3 (es) 2003-07-16
AU3143499A (en) 1999-10-11
IL138292A (en) 2005-08-31
JP2002506823A (ja) 2002-03-05
CZ20003256A3 (cs) 2001-04-11

Similar Documents

Publication Publication Date Title
NO20063853L (no) Kombinasjonsterapi for osteoporose
DE60318092D1 (de) Pharmazeutische zusammensetzung enthältend estetrolderivate und anwendung in der krebsbehandlung
DK1401438T3 (da) Anvendelse af cyclopamin i behandlingen af basalt cellecarcinom og andre tumorer
DK279790A (da) Aromatiske steroid-5-alfa-reduktaseinhibitorer
SE9700642D0 (sv) Medel och sätt för förebyggande och behandling av det metabola syndromet
CY1106319T1 (el) Τοπικη θepαπεια στη μασταλγια
DK1063998T3 (da) Lægemiddel til profylakse og/eller behandling af mammarkarcinom indeholdende en steroidal aromataseinhibitor
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
NO20024735L (no) Anvendelse av fulvestrant for behandling av resistent brystkreft
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
RU2000126276A (ru) Лекарственный препарат для профилактики и/или лечения рака молочной железы, содержащий стероидный ингибитор ароматазы
DE69935156D1 (de) hCG THERAPIE ZUR BEHANDLUNG VON METASTATISCHEM BRUSTKREBS
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
AU1799392A (en) Use of mullerian inhibiting substance for treatment of certain tumors
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
ES2145926T3 (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
EA200501568A1 (ru) 8β-ВИНИЛ 11β-(ω-ЗАМЕЩЁННЫЕ)АЛКИЛЭСТРА-1,3,5(10)-ТРИЕНЫ
NO885193L (no) Sammensetninger og fremgangsmaate for tilveiebringing av prevensjon og kontroll av brystkreft.
DE60234995D1 (de) Tatakrebs
IT1241456B (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
IT1314187B1 (it) Combinazione di differenti composizioni farmaceutiche per iltrattamento del carcinoma mammario e relativo uso
ITMI980955A1 (it) Combinazione di differenti composizioni farmaceutiche per il trattamento del carcinoma mammario e relativo metodo di somministrazione
ATE64372T1 (de) P-hydroxyzimtamid derivate und diese enthaltende melanininhibitoren.